Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2 | 141470940 | intron variant | C/A;T | snv |
|
Behavior and Behavior Mechanisms | 0.800 | 1.000 | 2 | 2010 | 2014 | ||||||||||
|
2 | 141164219 | intron variant | G/A | snv | 0.33 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
1.000 | 0.080 | 2 | 140268867 | intron variant | T/C | snv | 2.0E-02 |
|
Nutritional and Metabolic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 2 | 140268867 | intron variant | T/C | snv | 2.0E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
2 | 141204588 | intron variant | G/T | snv | 0.12 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
2 | 140963573 | intron variant | A/T | snv | 0.18 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||||
|
2 | 141857567 | intron variant | G/A;C | snv |
|
0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||||
|
2 | 141867184 | intron variant | G/A;C | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
1.000 | 0.080 | 2 | 140964558 | intron variant | A/G;T | snv |
|
Neoplasms; Eye Diseases | 0.700 | 1.000 | 1 | 2020 | 2020 | ||||||||
|
2 | 141805706 | non coding transcript exon variant | G/A | snv | 0.18 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
2 | 142074189 | intron variant | A/C | snv | 0.18 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.080 | 2 | 140665410 | intron variant | G/A;C | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.080 | 2 | 140665410 | intron variant | G/A;C | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
1.000 | 0.080 | 2 | 140292500 | intron variant | G/A | snv | 2.3E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 2 | 140292500 | intron variant | G/A | snv | 2.3E-02 |
|
Nutritional and Metabolic Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
2 | 141672738 | intron variant | A/C | snv | 0.13 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
1.000 | 0.040 | 2 | 140788186 | intron variant | T/C | snv | 0.43 |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
2 | 141535577 | intron variant | C/A | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
2 | 140639810 | intron variant | C/T | snv | 1.2E-03 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 2 | 141104341 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 2 | 142009864 | intron variant | C/T | snv | 0.32 |
|
Pathological Conditions, Signs and Symptoms | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||
|
2 | 141676101 | intron variant | T/C | snv | 0.13 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
2 | 141544934 | intron variant | G/T | snv | 0.15 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.040 | 2 | 140908502 | intron variant | A/G | snv | 2.7E-03 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.040 | 2 | 140908502 | intron variant | A/G | snv | 2.7E-03 |
|
0.700 | 1.000 | 1 | 2018 | 2018 |